Topic
biotech
6 articles
Signal Briefing: March 13, 2026
AI inference costs plummet along a steeper curve than expected, biotech and AI converge on drug discovery, and AI copyright cases set precedents that will shape the industry.
Signal Briefing: February 19, 2026
Model distillation reshapes the AI value chain, defense tech absorbs AI capabilities at scale, and biotech validation data strengthens the AI-pharma thesis.
Signal Briefing: February 16, 2026
Presidents' Day week opens with an AI policy crossroads, cloud capex projections for the year, and early quantum computing results that demand attention.
Signal Briefing: February 12, 2026
Inference scaling becomes the dominant cost challenge, biotech-AI convergence accelerates drug discovery, and climate tech draws increasing AI investment.
Signal Briefing: January 21, 2026
Cloud providers compete on AI differentiation, agent frameworks converge on graph-based orchestration, and Eli Lilly commits $1 billion to an AI co-innovation lab with NVIDIA.
Signal Briefing: January 14, 2026
Cloud earnings season approaches with AI revenue in focus, biotech AI applications advance, and talent migration patterns reshape the industry map.